Sang-Van Nguyen

Depression Outcomes Among Patients Treated With Fluoxetine for Stroke Recovery

Osvaldo P. Almeida, Graeme J. Hankey, Andrew H. Ford, Christopher Etherton‐Beer et autres

Importance: One in 3 adults experiences clinically significant symptoms of depression during the first year after a stroke, but evidence to support the use of antidepressants in this population remains scant. Objective: To investigate whether daily treatment with 20 mg of fluoxetine …

au (code pays fourni par la source)

Twelve-Month Outcomes of the AFFINITY Trial of Fluoxetine for Functional Recovery After Acute Stroke: AFFINITY Trial Steering Committee on Behalf of the AFFINITY Trial Collaboration

Graeme J. Hankey, Maree L. Hackett, Osvaldo P. Almeida, Leon Flicker et autres

Background and Purpose: The AFFINITY trial (Assessment of Fluoxetine in Stroke Recovery) reported that oral fluoxetine 20 mg daily for 6 months after acute stroke did not improve functional outcome and increased the risk of falls, bone fractures, and seizures. After trial …

au, gb, se, cn, vn, nz (code pays fourni par la source)

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

Graeme J. Hankey, Maree L. Hackett, Osvaldo P. Almeida, Leon Flicker et autres